Beyer Christoph, Boehm Anna, Pizzini Alex, Grubwieser Philipp, Feuchtner Gudrun, Bauer Axel, Weiss Guenter, Loeffler-Ragg Judith, Friedrich Guy, Plank Fabian
Department of Internal Medicine III - Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Internal Medicine II - Infectious Diseases, Pneumology and Rheumatology, Medical University of Innsbruck, Innsbruck, Austria.
Front Med (Lausanne). 2023 Jun 15;10:1181831. doi: 10.3389/fmed.2023.1181831. eCollection 2023.
Chronic respiratory diseases represent the third-leading cause of death on a global scale. Due to mutual symptoms with cardiovascular diseases and potential inappropriate attribution of symptoms, pulmonary diseases often remain undiagnosed. Therefore, we aimed to evaluate the prevalence of chronic respiratory disorders among symptomatic patients in whom suspected coronary artery disease (CAD) was ruled out.
After CAD was excluded by invasive coronary angiography (ICA), 50 patients with chest pain or dyspnea were prospectively enrolled in this study. All patients underwent lung function testing, including spirometry and diffusion measurements. At baseline and the 3-month follow-up, standardized assessments of symptoms (CCS chest pain, mMRC score, CAT score) were performed.
Chronic respiratory disease was diagnosed in 14% of patients, with a prevalence of 6% for chronic obstructive ventilation disorders. At 3-month follow-up, patients with normal lung function tests revealed a substantial improvement in symptoms (mean mMRC 0.70 to 0.33, = 0.06; median CAT 8 to 2, = 0.01), while those with pulmonary findings showed non-significant alterations or unchanged symptoms (mean mMRC 1.14 to 0.71, = 0.53; median CAT 6 to 6, = 0.52).
A substantial proportion of patients with an initial suspicion of coronary artery disease was diagnosed with underlying chronic respiratory diseases and exhibited persistent symptoms.
慢性呼吸道疾病是全球第三大死因。由于与心血管疾病有共同症状且症状可能归因不当,肺部疾病常常未被诊断出来。因此,我们旨在评估在排除疑似冠状动脉疾病(CAD)的有症状患者中慢性呼吸道疾病的患病率。
在通过有创冠状动脉造影(ICA)排除CAD后,前瞻性纳入50例胸痛或呼吸困难患者进行本研究。所有患者均接受肺功能测试,包括肺活量测定和弥散测量。在基线和3个月随访时,对症状进行标准化评估(CCS胸痛、mMRC评分、CAT评分)。
14%的患者被诊断为慢性呼吸道疾病,慢性阻塞性通气障碍的患病率为6%。在3个月随访时,肺功能测试正常的患者症状有显著改善(平均mMRC从0.70降至0.33,P = 0.06;CAT中位数从8降至2,P = 0.01),而有肺部异常表现的患者症状无显著变化或未改变(平均mMRC从1.14降至0.71,P = 0.53;CAT中位数从6降至6,P = 0.52)。
很大一部分最初怀疑患有冠状动脉疾病的患者被诊断为患有潜在的慢性呼吸道疾病并表现出持续症状。